Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Benson

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Blood Transfusion = Trasfusione Del Sangue|December 18, 2015
Beyond stopping the bleed: short-term episodic prophylaxis with recombinant activated factor FVII in haemophilia patients with inhibitorsSilva Zupančić Šalek, Günter Auerswald, Gary Benson, et al.
European Journal of Haematology|November 10, 2018
Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult-to-treat patientsRolf Ljung, Guenter Auerswald, Gary Benson, et al.
European Journal of Haematology|March 24, 2017
Outcome measures for adult and pediatric hemophilia patients with inhibitorsCedric Hermans, Günter Auerswald, Gary Benson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 14, 2019
Clinical evaluation of bleeds and response to haemostatic treatment in patients with acquired haemophilia: A global expert consensus statementAndreas Tiede, Paul Giangrande, Jerome Teitel, et al.
Plos One|October 11, 2012
GlycReSoft: a software package for automated recognition of glycans from LC/MS dataEvan Maxwell, Yan Tan, Yuxiang Tan, et al.
The Bone & Joint Journal|September 30, 2021
Oral tranexamic acid for an additional 24 hours postoperatively versus a single preoperative intravenous dose for reducing blood loss in total knee arthroplasty: results of a randomized controlled trial (TRAC-24)Paul Magill, Janet C Hill, Leeann Bryce, et al.
The Bone & Joint Journal|July 1, 2021
Oral tranexamic acid for an additional 24 hours postoperatively versus a single preoperative intravenous dose for reducing blood loss in total hip arthroplasty: results of a randomized controlled trial (TRAC-24)Paul Magill, J C Hill, Leeann Bryce, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 15, 2014
Rationale for individualizing haemophilia careBenny Sørensen, Günter Auerswald, Gary Benson, et al.
Blood Reviews|November 5, 2021
Hemophilia treatment in 2021: Choosing the"optimal" treatment using an integrative, patient-oriented approach to shared decision-making between patients and cliniciansCedric Hermans, Declan Noone, Gary Benson, et al.
BMC Bioinformatics|August 6, 2014
Clinical PathoScope: rapid alignment and filtration for accurate pathogen identification in clinical samples using unassembled sequencing dataAllyson L Byrd, Joseph F Perez-Rogers, Solaiappan Manimaran, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Blood Transfusion = Trasfusione Del Sangue|December 18, 2015
Beyond stopping the bleed: short-term episodic prophylaxis with recombinant activated factor FVII in haemophilia patients with inhibitorsSilva Zupančić Šalek, Günter Auerswald, Gary Benson, et al.
European Journal of Haematology|November 10, 2018
Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult-to-treat patientsRolf Ljung, Guenter Auerswald, Gary Benson, et al.
European Journal of Haematology|March 24, 2017
Outcome measures for adult and pediatric hemophilia patients with inhibitorsCedric Hermans, Günter Auerswald, Gary Benson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 14, 2019
Clinical evaluation of bleeds and response to haemostatic treatment in patients with acquired haemophilia: A global expert consensus statementAndreas Tiede, Paul Giangrande, Jerome Teitel, et al.
Plos One|October 11, 2012
GlycReSoft: a software package for automated recognition of glycans from LC/MS dataEvan Maxwell, Yan Tan, Yuxiang Tan, et al.
The Bone & Joint Journal|September 30, 2021
Oral tranexamic acid for an additional 24 hours postoperatively versus a single preoperative intravenous dose for reducing blood loss in total knee arthroplasty: results of a randomized controlled trial (TRAC-24)Paul Magill, Janet C Hill, Leeann Bryce, et al.
The Bone & Joint Journal|July 1, 2021
Oral tranexamic acid for an additional 24 hours postoperatively versus a single preoperative intravenous dose for reducing blood loss in total hip arthroplasty: results of a randomized controlled trial (TRAC-24)Paul Magill, J C Hill, Leeann Bryce, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 15, 2014
Rationale for individualizing haemophilia careBenny Sørensen, Günter Auerswald, Gary Benson, et al.
Blood Reviews|November 5, 2021
Hemophilia treatment in 2021: Choosing the"optimal" treatment using an integrative, patient-oriented approach to shared decision-making between patients and cliniciansCedric Hermans, Declan Noone, Gary Benson, et al.
BMC Bioinformatics|August 6, 2014
Clinical PathoScope: rapid alignment and filtration for accurate pathogen identification in clinical samples using unassembled sequencing dataAllyson L Byrd, Joseph F Perez-Rogers, Solaiappan Manimaran, et al.
Pageof 8